Eurofins Viracor BioPharma Services

What Eurofins Viracor BioPharma Services does

Eurofins Viracor BioPharma Services is a U.S. specialty clinical diagnostics laboratory that provides molecular diagnostic, immunology, infectious disease, transplant, and allergy testing for immunocompromised and critically ill patients. Founded in 1983 as IBT Laboratories and operating today as a 100% subsidiary of Eurofins Scientific SE following a 2014 acquisition for approximately $255 million, the company runs CLIA-certified, CAP-accredited laboratories in Lenexa (Kansas), Lee's Summit (Missouri), and Los Angeles, serving approximately 75% of U.S. transplant programs and more than 4,000 physicians, hospitals, commercial laboratories, and biopharmaceutical companies.

The company's core technology stack centers on proprietary molecular assays — PCR, hybrid-capture next-generation sequencing (NeXGen® Fungal/AFB NGS), and FDA-cleared immune function testing (ImmuKnow®) — alongside licensed predictive algorithms (aGVHD algorithms from the Mount Sinai MAGIC consortium) and trademarked persistence assays for CAR T-cell therapies (ExPeCT™). A nearly 3,000-assay menu covers allergy, immunology, infectious disease, and transplant categories, with operational differentiators including 8–12 hour same-day turnaround for infectious disease testing and ~24-hour turnaround for CAR T-cell and aGVHD assays.

Revenue is generated primarily through transaction-fee laboratory testing services billed to healthcare providers, hospitals, transplant programs, reference laboratories, and biopharma companies on a quote-based, negotiated-pricing model. The go-to-market is enterprise field sales with supporting online ordering, HL7 EHR interface integration, at-home specimen collection (Labs@HOME), and a Medical Advisory Board guiding assay development. A dedicated BioPharma Services brand extends the commercial footprint into therapeutics, vaccines, and cell/gene therapy clinical research testing.

Name

Eurofins Viracor BioPharma Services

Legal name

Eurofins Viracor, LLC

Website

https://eurofins-viracor.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

101–250 employees

Short description

Eurofins Viracor BioPharma Services is a U.S. specialty clinical diagnostics laboratory providing molecular, immunology, infectious disease, transplant, and allergy testing for immunocompromised patients, serving approximately 75% of U.S. transplant programs and more than 4,000 healthcare and biopharma clients.

Ownership category

akta.pro rank

Product category

Specialty Clinical Diagnostics Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

akta.pro secondary industries

Clinical Research & Trial Central Laboratories (HLAFAMAL), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Specialty clinical diagnostics
• Transplant diagnostic testing
• Infectious disease laboratory
• Immunology laboratory services
• Allergy diagnostic testing

Headquarters

HQ city

Lenexa

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Diagnostic Laboratory Testing Services: Specialty diagnostic laboratory services providing testing for immunocompromised and critical patients. Services include molecular diagnostics, immunology, infectious disease, transplant, and allergy testing. Revenue generated through test fees charged to healthcare providers, hospitals, transplant programs, and biopharmaceutical companies.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels11 records

Core offering

Eurofins Viracor is a specialty clinical diagnostics laboratory that performs nearly 3,000 assays in infectious disease, immunology, transplant, and allergy testing for immunocompromised and critically ill patients. It delivers proprietary and FDA-cleared tests (ImmuKnow, ExPeCT CAR T, NeXGen Fungal/AFB NGS, aGVHD predictive algorithms) from CLIA/CAP accredited labs in Lenexa, KS and Los Angeles, CA to hospitals, transplant programs, reference labs, and biopharmaceutical companies, with turnaround times as fast as 8–12 hours for infectious disease results. The BioPharma Services arm develops, customizes, and validates assays for complex clinical research testing in therapeutics, vaccines, and cell and gene therapies.

Product overview

Eurofins Viracor operates as a specialty diagnostics laboratory offering a comprehensive test menu of nearly 3,000 assays across four primary testing categories: Infectious Disease, Immunology, Transplant, and Allergy. The company's portfolio includes molecular diagnostic testing services (PCR, NGS), immune function monitoring, and specialized panels. Core products include the NeXGen® Fungal/AFB NGS assay for respiratory pathogen detection, the ExPeCT™ CAR T-cell persistence assays for oncology monitoring, ImmuKnow® for transplant immunosuppression management, and various infectious disease PCR panels. Testing is delivered through multiple channels including online ordering, HL7 interface integration, and traditional specimen submission, with turnaround times as fast as 8-12 hours for infectious disease results.

Differentiator

Problem solved

Functional benefit

Brands

• ExPeCT CAR T: CAR T-cell persistence assays for monitoring CAR T-cell therapy expansion and persistence in cancer treatment.
• NeXGen Fungal / AFB NGS
• ImmuKnow

Products and services

• NeXGen® Fungal / AFB NGS Assay
• ExPeCT™ CAR T-Cell Persistence Assays
• ImmuKnow® Immune Cell Function Assay
• CMV Testing Suite
• Respiratory Virus Testing
• Aspergillus PCR Panel
• Alpha-Gal IgE Assay
• Pneumococcal Antibody Assays (32-serotype panel)
• aGVHD Predictive Algorithms
• 16S NGS Bacterial Meningitis Test
• JC Virus PCR
• Zika Virus Real-time RT-PCR
• BioPharma Clinical Research Testing Services

Quantifiable outcome

• 13% increase in 1-year patient survival post-transplant when using ImmuKnow assay for immunosuppression optimization
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature10 records

Partnerships

Four partnerships are on record, tiered core.

• Medical Advisory BoardcoreStrategic or Co-development Partner · 21 August 2018Medical Advisory Board with inaugural members Michael G. Ison (Northwestern Memorial Hospital), Michele Morris (University of Miami), and Betsy Herold (Albert Einstein College of Medicine). Board meets regularly to discuss clinical needs and bring innovative diagnostic tests to market.
• Mount Sinai Acute GVHD International Consortium (MAGIC)coreStrategic or Co-development Partner · 8 August 2018Licensed predictive aGVHD algorithms developed by James Ferrara and John Levine at Mount Sinai. Validated in conjunction with 17 HCT centers. Three algorithm versions for pre-symptomatic, symptomatic onset, and post-treatment use.
• National Kidney Registry (NKR)coreStrategic or Co-development Partner · 13 August 2015Partnership to streamline pre-transplant serology testing for kidney donors across NKR's 75 member centers. Reduced pre-op serology turnaround to under 2 days from 10 days, increasing living donor transplantation efficiency and reducing paired exchange failures.
• Eurofins ScientificcoreOthersEurofins Viracor is a 100% subsidiary of Eurofins Scientific (EUFI.PA), the global leader in bio-analytical testing. Acquired Viracor-IBT in 2014 for approximately $255 million.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• NeoGenomics: Specialty oncology-focused clinical laboratory offering molecular diagnostics, NGS, and immune monitoring for cancer patients. Comparable to Eurofins Viracor in specialty molecular and immune monitoring assays, particularly for oncology applications like CAR T monitoring.
• ARUP Laboratories: Specialty reference laboratory affiliated with the University of Utah, providing esoteric testing in infectious disease, immunology, transplant diagnostics, and molecular genetics. Highly comparable to Eurofins Viracor as a specialty-focused reference lab serving hospitals with complex diagnostic needs.
• BioReference Laboratories (OPKO Health): Specialty clinical laboratory offering oncology, urology, women's health, and infectious disease diagnostics. Overlaps with Eurofins Viracor's specialty diagnostics and clinical trial testing capabilities, particularly in immunology and molecular diagnostics.
• Mayo Clinic Laboratories: Hospital-affiliated reference laboratory offering thousands of esoteric and specialty tests across transplant, infectious disease, immunology, and genetics. Directly comparable to Eurofins Viracor in serving hospitals and transplant programs with complex specialty testing.
• ICON plc (PRA Health / ICON Central Labs): Global clinical CRO with central laboratory services supporting clinical trials across multiple therapeutic areas including immunology and oncology. Comparable to Eurofins Viracor's BioPharma Services central lab offerings, with stronger global geographic footprint.
• Q² Solutions (IQVIA/Quest joint venture): Global central laboratory services provider supporting clinical trials across immunoassays, flow cytometry, genomics, and specialty biomarkers. Directly comparable to Eurofins Viracor's biopharma central lab and specialty biomarker testing offerings, with broader global reach.

Broad incumbents

• Charles River Laboratories: Major CRO providing preclinical and clinical laboratory services, including central lab and specialty biomarker testing for biopharmaceutical clients. Overlaps with Eurofins Viracor's biopharma central lab and specialty testing capabilities, though Charles River's focus is broader across drug development stages.
• Labcorp (Laboratory Corporation of America): One of the largest U.S. clinical reference laboratory networks offering a broad diagnostic menu plus central lab services for clinical trials through Labcorp Drug Development. Comparable to Eurofins Viracor in central lab/biomarker support for biopharma, though Labcorp's portfolio is much broader and less specialized in transplant/immunocompromised niches.
• Sonic Healthcare USA: International diagnostics group with U.S. specialty and reference lab operations. Comparable as a reference lab operator with specialty testing capabilities across infectious disease, immunology, and clinical trial support.
• Quest Diagnostics: Major U.S. clinical reference lab with broad infectious disease, immunology, and molecular diagnostics menus plus specialty/esoteric testing services. Overlaps with Eurofins Viracor in clinical diagnostics and increasingly in specialty biomarker and biopharma services, though Quest serves a much broader ambulatory market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/EurofinsViracor
• YouTubeyoutube.com/@eurofinsviracor
• Facebookfacebook.com/EurofinsViracorKS
• LinkedInlinkedin.com/company/eurofins-viracor-biopharma-services
• Instagraminstagram.com/eurofinsviracor

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurofins Viracor BioPharma Services